Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Rheumatology Coding Corner Answer: Gout Visit for Established Patient

  |  

CPT: 99213, 89060 ICD-10: M10.072 Coding Rationale This is an established out­patient visit. The encounter is coded as 99213 because it included: History—Expanded problem-focused history. The history of present illness was brief, the review of systems was extended and the past medical and social history was documented. Examination—Detailed. There were seven organ systems examined. This…

RheumPAC Backs Pro-Rheumatology Congressional Candidate Dr. Matt Heinz from Arizona

  |  

RheumPAC is the ACR’s political action committee dedicated to increasing rheumatology’s presence on Capitol Hill. It is the only PAC dedicated to the interests of all rheumatologists and their patients. RheumPAC began in 2007 with the purpose of building contacts, influence and visibility within Washington, D.C. for rheumatology. RheumPAC works to support and elect pro-rheumatology…

Rheumatology Research Workshop Encourages Collaboration, Career Mentoring

  |  

The Rheumatology Research Workshop (RRW), a two-day meeting designed to promote interactions between early and established investigators to foster collaboration and facilitate career mentoring, was held this year on June 24–25 in Atlanta. Each year, the workshop includes scientific lectures, elevator pitch presentations, poster sessions and scheduled time for interaction with senior investigators to exchange…

Preceptorships, Mentors Steer Rheumatology

  |  

Brian Le, MD, a rheumatology fellow at the Medical College of Georgia at Augusta University (MCG), credits an excellent mentor and two Rheumatology Research Foundation preceptorships with guiding his career toward rheumatology. “Working with Dr. Laura Carbone has opened up a lot of doors for me,” says Dr. Le. “I wouldn’t have such a great relationship with…

Shifting Health Policy Landscape Brings Opportunities, Responsibility to Advocate for Rheumatology

Joan M. Von Feldt, MD, MSEd, FACR, FACP  |  

Heraclitus of Ephesus (c. 500 BC) is credited with the saying, “The only constant is change.” Now, centuries later, change is meteoric, and especially in healthcare and health policy, the pace of change is relentless. Rheumatology and other specialties continue to face challenges that threaten the ability to deliver compassionate, competent care to patients. The…

Do Fatty Acids Underlie Rheumatoid Arthritis Pathology?

  |  

According to a new study, patients with aggressive rheumatoid arthritis (RA) have lower levels of non-esterified fatty acids, which coincide with an enhanced Th1 response. Researchers suggest that lower EPA and DHA at the onset of RA may exacerbate inflammation, and fatty acids may become a novel therapeutic target for the disease…

Roche Gets Boost from FDA in Bid to Expand Uses for Actemra

Reuters Staff  |  

ZURICH (Reuters)—The U.S. Food and Drug Administration has granted breakthrough status to Roche’s rheumatoid arthritis medication Actemra (tocilizumab) for giant cell arteritis, the Swiss drugmaker said, a step which could help it broaden applications for the medicine. Giant cell arteritis is a chronic, potentially life-threatening autoimmune condition caused by inflammation of large and medium-sized arteries,…

ICD-10 2.0: An Evolving Data Set

  |  

One year after the official go-live of the International Classification of Diseases, 10th revision (ICD-10), the coding language is scheduled to undergo an evolution, with nearly 1,975 additions, more than 300 deletions and 425 revisions. This brings the total set of diagnosis codes to more than 71,480. The new and revised clinical modification codes (ICD-10-CM)…